Non-alcoholic fatty liver disease (NAFLD)
NAFLD is currently the most common liver disorder both in the US and Europe. The fatty liver may progress to non-alcoholic steatohepatitis (NASH), which markedly increases the risk of cirrhosis and hepatocellular carcinoma. NAFLD is the hepatic manifestation of the metabolic syndrome and characterizes the majority of patients with type 2 diabetes.
1. To advance our understanding of the prevalence, diagnosis, pathogenesis, prevention and treatment of NAFLD.
2. To enable hepatologists and diabetologists and other specialists in cognate disciplines to interact.
EASD: Official endorsement
Guidelines for the NAFLD Study Group
The NAFLD Study Group will follow the for Guidelines endorsed by the Executive Committee of the EASD (European Association for the Study of Diabetes) on 14 January 2013.
The presentations of the Study Groups Spring webinars posted online at the EGIR&NAFLD Study Groups YouTube channel
Stay tune for fur next EVENT
NAFLD STUDY GROUP ASBTRACT WEBINAR 2022
We kindly invite you to the NAFLD Abstract session that will take place on ZOOM on Wednesday, November 23 17:00-19:00 (Rome)
Registration is free, but pre-registration is required. Here is the link to register in advance for this webinar:
After registering, you will receive a confirmation email containing information about joining the webinar.
Please, feel free to share this announcement with your colleagues/students.
We look forward to seeing you virtually…
EGIR STUDY GROUP VIRTUAL MEETING & ABSTRACTS SESSION - “ENERGY METABOLISM AND METABOLIC DISEASES”
Nov 7-9 2022 5.00-7:00 PM (Rome)
We present a two-hour session with three outstanding lectures on November 7th and 9th, followed by a panel discussion. See the program here. The event will take place via Zoom; we will post more registration information here soon, registration is free, but pre-registration is required.
On November 8th, we will have a section with selected abstracts presentation on metabolism (not only energy metabolism but also insulin secretion and action in different tissues); more information about submission of abstracts below.
We hope you can join us.
CALL FOR ABSTRACT WEBINAR WITH PRIZE
This event allows the presenters to foster their work in front of a top-level interdisciplinary audience of scientists, outstanding global experts, and students.
We welcome abstracts on insulin action and secretion, diabetes and energy metabolism from researchers (junior and seniors) affiliated with universities, research institutes, or industry. A 500 euro award prize will go to the best abstract from a young presenter (<43 years old).
The deadline for submission of abstracts is 26 October.
To submit your abstract, use the word format attached ON or BEFORE 26 November 2022 18:00 hrs CET in reply to this email. (please do not send PDF or other formats).
Notification of review outcome: 3 November.